Healthcare provider profile · identity verified

Janice E Luth, MD

Family Practice · MONETA, VA · NPI 1912905894

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	369	100
Levothyroxine Sodium	Levothyroxine Sodium	317	57
Omeprazole	Omeprazole	211	57
Losartan Potassium	Losartan Potassium	181	51
Lisinopril	Lisinopril	161	44
Hydrochlorothiazide	Hydrochlorothiazide	153	43
Metformin Hcl Er	Metformin Hcl	129	34
Rosuvastatin Calcium	Rosuvastatin Calcium	127	35
Amlodipine Besylate	Amlodipine Besylate	122	34
Metoprolol Succinate	Metoprolol Succinate	113	28
Potassium Chloride	Potassium Chloride	111	25
Gabapentin	Gabapentin	110	31
Furosemide	Furosemide	101	20
Metformin Hcl	Metformin Hcl	84	20
Trazodone Hcl	Trazodone Hcl	76	17
Famotidine	Famotidine	71	19
Albuterol Sulfate Hfa	Albuterol Sulfate	70	24
Allopurinol	Allopurinol	68	18
Metoprolol Tartrate	Metoprolol Tartrate	64	14
Escitalopram Oxalate	Escitalopram Oxalate	62	14
Montelukast Sodium	Montelukast Sodium	59	18
Alendronate Sodium	Alendronate Sodium	57	19
Pantoprazole Sodium	Pantoprazole Sodium	55	13
Sertraline Hcl	Sertraline Hcl	51	15
Atenolol	Atenolol	50	16
Lamotrigine	Lamotrigine	49	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	47	12
Nystatin	Nystatin	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	13
Alprazolam	Alprazolam	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	17
Glipizide	Glipizide	42	11
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Latanoprost	Latanoprost	31	suppressed
Meloxicam	Meloxicam	31	suppressed
Risperidone	Risperidone	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Lorazepam	Lorazepam	28	11
Prednisone	Prednisone	28	12
Carvedilol	Carvedilol	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Memantine Hcl Er	Memantine Hcl	26	suppressed
Eliquis	Apixaban	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Finasteride	Finasteride	24	suppressed
Liothyronine Sodium	Liothyronine Sodium	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Valsartan	Valsartan	24	suppressed
Sodium Fluoride	Fluoride (Sodium)	23	suppressed
Baclofen	Baclofen	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Metolazone	Metolazone	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Glycopyrrolate	Glycopyrrolate	20	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Ozempic	Semaglutide	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Rivastigmine	Rivastigmine Tartrate	17	suppressed
Topiramate	Topiramate	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Cholestyramine Light	Cholestyramine	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Budesonide	Budesonide	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Galantamine Hbr	Galantamine Hbr	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Glyburide	Glyburide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Torsemide	Torsemide	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error